HSBC Holdings’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23,800
Closed -$4.93M 2932
2025
Q4
$4.93M Buy
23,800
+4,500
+23% +$847K ﹤0.01% 1216
2025
Q3
$3.04M Buy
19,300
+3,500
+22% +$541K ﹤0.01% 1358
2025
Q2
$2.66M Sell
15,800
-13,100
-45% -$1.94M ﹤0.01% 1376
2025
Q1
$3.96M Buy
28,900
+20,000
+225% +$2.55M ﹤0.01% 1190
2024
Q4
$1.05M Buy
+8,900
New +$1.04M ﹤0.01% 1769
2022
Q4
Sell
-3,900
Closed -$263K 3059
2022
Q3
$263K Hold
3,900
﹤0.01% 2484
2022
Q2
$206K Buy
+3,900
New +$222K ﹤0.01% 2871
2013
Q3
Sell
-863,639
Closed -$40.8M 1664
2013
Q2
$40.8M Buy
+863,639
New +$39.4M 0.12% 176

Other funds holding CAH

HSBC Holdings's CAH Position: Q1 2026 in Review

HSBC Holdings reduced its Cardinal Health (CAH) stake by 15% in Q1 2026, selling an estimated $19.9M and leaving 519,844 shares worth $110M. The position accounts for 0.06% of the portfolio, ranked #309.

HSBC Holdings first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. The position peaked at $126M in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • HSBC Holdings held 519,844 shares of Cardinal Health worth $110M as of Q1 2026.
  • HSBC Holdings sold 92,629 Cardinal Health shares in Q1 2026, an estimated $19.9M.
  • Cardinal Health made up 0.06% of HSBC Holdings's portfolio in Q1 2026, its #309 holding.
  • HSBC Holdings first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's Cardinal Health position peaked at $126M in Q4 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.